Impact of mast cells on multiple sclerosis: inhibitory effect of natalizumab (original) (raw)

Important role of mast cells in multiple sclerosis

Pio Conti

View PDFchevron_right

Mast cells in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis

Mario Colombo

International journal of molecular sciences, 2012

View PDFchevron_right

Mast Cells: The Key to Multiple Sclerosis?

Scientific Research Publishing

View PDFchevron_right

Ultrastructural evidence of brain mast cell activation without degranulation in monkey experimental allergic encephalomyelitis

Theoharis Theoharides

Journal of Neuroimmunology, 2003

View PDFchevron_right

Mast cells in neuroinflammation and brain disorders

Ronald Oosting

Neuroscience and biobehavioral reviews, 2017

View PDFchevron_right

Mast cells in neuroimmune function: Neurotoxicological and neuropharmacological perspectives

WENDY PURCELL

Neurochemical Research, 1995

View PDFchevron_right

Curbing Inflammation in Multiple Sclerosis and Endometriosis: Should Mast Cells Be Targeted?

David A Hart

International journal of inflammation, 2015

View PDFchevron_right

Human Mast Cells Stimulate Activated T Cells

A. Manola

Annals of the New York Academy of Sciences, 2008

View PDFchevron_right

Mast cells as effector cells: a co-stimulating question

Francesca Levi-schaffer

Trends in Immunology, 2007

View PDFchevron_right

Mast cells in brains during experimental allergic encephalomyelitis in Lewis rats

S. Mørk

Journal of the Neurological Sciences, 1991

View PDFchevron_right

Critical role of mast cells in inflammatory diseases and the effect of acute stress

Theoharis Theoharides

Journal of Neuroimmunology, 2004

View PDFchevron_right

Treatment with Natalizumab in Relapsing–Remitting Multiple Sclerosis Patients Induces Changes in Inflammatory Mechanism

Celia Oreja-guevara

Journal of Clinical Immunology, 2000

View PDFchevron_right

Activation of Mast Cells by Neuropeptides: The Role of Pro-inflammatory and Anti-Inflammatory Cytokines

Spyridon Kritas

View PDFchevron_right

Significant Contribution of Mouse Mast Cell Protease 4 in Early Phases of Experimental Autoimmune Encephalomyelitis

Marjan Gharagozloo

Mediators of inflammation, 2016

View PDFchevron_right

Relationship between Mast Cells and Autoimmune Diseases

Felipe Valença Pereira

View PDFchevron_right

Natalizumab Exerts Direct Signaling Capacity and Supports a Pro-Inflammatory Phenotype in Some Patients with Multiple Sclerosis

Friederike Berberich-siebelt, Ellen Leich

PLoS ONE, 2012

View PDFchevron_right

Mast cell activation disease

El Lateef

2016

View PDFchevron_right

Mast cells and inflammation

Theoharis Theoharides

Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2012

View PDFchevron_right

Mast Cells in Allergic and Inflammatory Diseases

Theoharis Theoharides

Current Pharmaceutical Design, 2012

View PDFchevron_right

Mast cells, glia and neuroinflammation: partners in crime?

Pietro Giusti

Immunology, 2014

View PDFchevron_right

Hydroxyzine inhibits experimental allergic encephalomyelitis (EAE) and associated brain mast cell activation

Theoharis Theoharides

International Journal of Immunopharmacology, 2000

View PDFchevron_right

Mast cells in EAE: Distribution in the CNS and in vitro activation by MBP and neuropeptides

Oded Abramsky, Francesca Levi-schaffer

Journal of Neuroimmunology, 1991

View PDFchevron_right

The effects of natalizumab on inflammatory mediators in multiple sclerosis: prospects for treatment‐sensitive biomarkers

Mohsen Khademi

European Journal of Neurology, 2009

View PDFchevron_right

Editorial: Mast Cells in Itch, Pain and Neuro-Inflammation

Theoharis Theoharides

Frontiers in Cellular Neuroscience

View PDFchevron_right

Mast cells: an expanding pathophysiological role from allergy to other disorders

nirmal singh

Naunyn-Schmiedeberg's Archives of Pharmacology, 2012

View PDFchevron_right

Mast cells and mast cell activation syndrome: what's new?

Tiago Rama

Arquivos de Asma, Alergia e Imunologia, 2023

View PDFchevron_right

Mast cells in the brain: evidence and functional significance

Rae Silver

Trends in Neurosciences, 1996

View PDFchevron_right

Multiple sclerosis: the role of cytokines in pathogenesis and in therapies

Amedeo Amedei

International journal of molecular sciences, 2012

View PDFchevron_right

Induction of systemic TNFα in Natalizumab-treated multiple sclerosis

Mohsen Khademi

European Journal of Neurology, 2008

View PDFchevron_right

Mast Cell Involvement in the Pathogenesis of Selected Musculoskeletal Diseases

Dorota Formanowicz

Life

View PDFchevron_right

Exploring potential mechanisms of action of natalizumab in secondary progressive multiple sclerosis

Diego Cadavid

Therapeutic advances in neurological disorders, 2016

View PDFchevron_right

Clinical Immunological Correlations in Patients with Multiple Sclerosis Treated with Natalizumab

Septimiu Voidazan

Brain Sciences, 2020

View PDFchevron_right

Mast cell disorders in Ehlers-Danlos syndrome

Anne Maitland

American Journal of Medical Genetics Part C: Seminars in Medical Genetics

View PDFchevron_right

Mast cells in health and disease: from basic science to clinical application

Marcus Maurer

Expert Opinion on Therapeutic Targets, 2008

View PDFchevron_right

Nervous-system-associated mast cells: Gatekeepers of neural and immune interactions

Edward Orr

Drug Development Research, 1988

View PDFchevron_right